Insider Trading & Executive Data
Start Free Trial
63 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Hippo Holdings Inc. is an insurtech-focused insurance holding company operating three reportable segments: Services (consumer agency), Insurance-as-a-Service (Spinnaker acting as a fronting carrier that cedes most risk), and the Hippo Home Insurance Program (direct Hippo-branded homeowners coverage). The business mixes fee income, underwriting margin where it retains risk, and investment income on float, and differentiates via a full‑stack technology platform, proprietary underwriting/quoting engines and data-driven loss-prevention services. Management has tightened underwriting and reinsurance since mid‑2023 (higher retention on primary homeowners, selective proportional cover, XOL/cat bonds) and taken cost actions, producing material improvement in loss ratios, premium retention and adjusted EBITDA in 2024–H1 2025. The company is highly state‑regulated, sensitive to catastrophe seasonality, reinsurance capacity, reserve adequacy and capital/regulatory thresholds (e.g., Spinnaker’s >$500M DWP and related statutory capital actions).
Compensation for Hippo executives is likely to emphasize insurance‑specific performance metrics in addition to traditional growth goals: underwriting profitability (loss ratios, combined ratio), net earned premium and premium retention, adjusted EBITDA or adjusted net income, and return on statutory capital given Spinnaker’s capital importance. Because Hippo is an insurtech, equity‑linked pay (stock awards, options, performance shares) and long‑term incentive plans are probable to retain key technical, data and underwriting talent while aligning incentives to rebuild underwriting discipline and ROE. Short‑term bonuses are likely tied to underwriting outcomes, reserve development and successful reinsurance negotiations or capital actions (e.g., surplus note issuance), and compensation committees will pay special attention to reserve/case‑development sensitivity given its material impact on results. Regulatory constraints (state holding‑company approval, ORSA/RBC outcomes) and potential future capital raises can also indirectly affect pay design, vesting, and dilution expectations.
Insider trading activity at Hippo is likely influenced by the timing of material underwriting and capital events — e.g., quarterly reserve releases or adverse development, catastrophe seasons (wildfires, hurricanes), reinsurance treaty renewals, divestitures (First Connect sale) and capital transactions (surplus note, equity raises). Expect heightened insider selling following visible improvement in metrics (Q2 2025 GAAP net income and positive adjusted EBITDA) or after lock‑up/vesting events, while opportunistic buys may be rarer but could signal management conviction in continued underwriting recovery. Monitor Form 4 filings for option exercises and subsequent sales (common with growth‑stage public companies), clustered executive sales near period ends, and use of Rule 10b5‑1 plans; any sudden, large sales tied to reserve deterioration or capital needs should be treated as potential red flags. Finally, state insurance regulation and holding‑company approvals can impose blackout windows or additional disclosure expectations, increasing the informational value of the timing and magnitude of insider transactions.